Prothena Q1 Earnings Miss Estimates, Focus on Key Readouts in 2025

• click to rate

  Posted by Two Blokes May 9 - Filed in Stock - 2 views
  
  PRTA posts a wider-than-expected first-quarter loss. Investors will focus on important readouts on birtamimab and PRX012 later in 2025.